86 related articles for article (PubMed ID: 19649883)
1. Signal transduction drug discovery: targets, mechanisms and structure-based design.
Dalgarno DC; Metcalf CA; Shakespeare WC; Sawyer TK
Curr Opin Drug Discov Devel; 2000 Sep; 3(5):549-64. PubMed ID: 19649883
[TBL] [Abstract][Full Text] [Related]
2. Src homology-2 domains: structure, mechanisms, and drug discovery.
Sawyer TK
Biopolymers; 1998; 47(3):243-61. PubMed ID: 9817027
[TBL] [Abstract][Full Text] [Related]
3. Protein-tyrosine phosphatases: structure, mechanism, and inhibitor discovery.
Burke TR; Zhang ZY
Biopolymers; 1998; 47(3):225-41. PubMed ID: 9817026
[TBL] [Abstract][Full Text] [Related]
4. SH2 and PTB domains in tyrosine kinase signaling.
Schlessinger J; Lemmon MA
Sci STKE; 2003 Jul; 2003(191):RE12. PubMed ID: 12865499
[TBL] [Abstract][Full Text] [Related]
5. Phosphoryltyrosyl mimetics in the design of peptide-based signal transduction inhibitors.
Burke TR; Yao ZJ; Liu DG; Voigt J; Gao Y
Biopolymers; 2001; 60(1):32-44. PubMed ID: 11376431
[TBL] [Abstract][Full Text] [Related]
6. The PTB domain: a modular domain with multiple function.
O'Bryan JP
Curr Opin Drug Discov Devel; 1999 Sep; 2(5):505-18. PubMed ID: 19649978
[TBL] [Abstract][Full Text] [Related]
7. 14-3-3 proteins; bringing new definitions to scaffolding.
Tzivion G; Shen YH; Zhu J
Oncogene; 2001 Oct; 20(44):6331-8. PubMed ID: 11607836
[TBL] [Abstract][Full Text] [Related]
8. SRC homology-2 inhibitors: peptidomimetic and nonpeptide.
Sawyer TK; Bohacek RS; Dalgarno DC; Eyermann CJ; Kawahata N; Metcalf CA; Shakespeare WC; Sundaramoorthi R; Wang Y; Yang MG
Mini Rev Med Chem; 2002 Oct; 2(5):475-88. PubMed ID: 12370048
[TBL] [Abstract][Full Text] [Related]
9. Phosphotyrosyl mimetics in the development of signal transduction inhibitors.
Burke TR; Lee K
Acc Chem Res; 2003 Jun; 36(6):426-33. PubMed ID: 12809529
[TBL] [Abstract][Full Text] [Related]
10. Kinome signaling through regulated protein-protein interactions in normal and cancer cells.
Pawson T; Kofler M
Curr Opin Cell Biol; 2009 Apr; 21(2):147-53. PubMed ID: 19299117
[TBL] [Abstract][Full Text] [Related]
11. Oncogenes, Protein Tyrosine Kinases, and Signal Transduction.
Liu D; Wang LH
J Biomed Sci; 1994 Mar; 1(2):65-82. PubMed ID: 11725009
[TBL] [Abstract][Full Text] [Related]
12. PTB or not to be: promiscuous, tolerant and Bizarro domains come of age.
Farooq A; Zhou MM
IUBMB Life; 2004 Sep; 56(9):547-57. PubMed ID: 15590561
[TBL] [Abstract][Full Text] [Related]
13. CH/pi hydrogen bonds determine the selectivity of the Src homology 2 domain to tyrosine phosphotyrosyl peptides: an ab initio fragment molecular orbital study.
Ozawa T; Okazaki K
J Comput Chem; 2008 Dec; 29(16):2656-66. PubMed ID: 18484636
[TBL] [Abstract][Full Text] [Related]
14. Incorporation of phosphotyrosyl mimetic 4-(phosphonodifluoromethyl)phenylalanine (F2Pmp) into signal transduction-directed peptides.
Yao ZJ; Lee K; Burke TR
Methods Mol Biol; 2005; 298():91-103. PubMed ID: 16044542
[TBL] [Abstract][Full Text] [Related]
15. Structure and function of protein kinases and protein phosphatases.
Musgrave IF
IDrugs; 1998 Oct; 1(6):617-9. PubMed ID: 18465603
[TBL] [Abstract][Full Text] [Related]
16. Structural insight into partner specificity and phosphoryl transfer in two-component signal transduction.
Casino P; Rubio V; Marina A
Cell; 2009 Oct; 139(2):325-36. PubMed ID: 19800110
[TBL] [Abstract][Full Text] [Related]
17. Protein phosphorylation and signal transduction modulation: chemistry perspectives for small-molecule drug discovery.
Sawyer TK; Shakespeare WC; Wang Y; Sundaramoorthi R; Huang WS; Metcalf CA; Thomas M; Lawrence BM; Rozamus L; Noehre J; Zhu X; Narula S; Bohacek RS; Weigele M; Dalgarno DC
Med Chem; 2005 May; 1(3):293-319. PubMed ID: 16787325
[TBL] [Abstract][Full Text] [Related]
18. Evolution of protein phosphatases in plants and animals.
Moorhead GB; De Wever V; Templeton G; Kerk D
Biochem J; 2009 Jan; 417(2):401-9. PubMed ID: 19099538
[TBL] [Abstract][Full Text] [Related]
19. Protein tyrosine kinases as new potential targets against human schistosomiasis.
Dissous C; Ahier A; Khayath N
Bioessays; 2007 Dec; 29(12):1281-8. PubMed ID: 18022808
[TBL] [Abstract][Full Text] [Related]
20. Structure-based design of molecular cancer therapeutics.
van Montfort RL; Workman P
Trends Biotechnol; 2009 May; 27(5):315-28. PubMed ID: 19339067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
